Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,003 public trials 391 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01696058

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1222.52.02090 Boehringer Ingelheim Investigational Site Anniston, Alabama, United States
  • 1222.52.02046 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1222.52.02014 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1222.52.02017 Boehringer Ingelheim Investigational Site Montgomery, Alabama, United States
View all 94 locations
View Trial Details
Completed

A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

NCT02172560

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site 61501 Garran, Australian Capital Territory, Australia
  • Boehringer Ingelheim Investigational Site 61403 Clayton, New South Wales, Australia
  • Boehringer Ingelheim Investigational Site 61502 Adelaide, South Australia, Australia
  • Boehringer Ingelheim Investigational Site 61401 Woodsville South, South Australia, Australia
View all 19 locations
View Trial Details
Completed

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01636076

Conditions
COPD, Chronic Disease, Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Concord, New South Wales, Australia
  • Novartis Investigative Site Kogarah, New South Wales, Australia
  • Novartis Investigative Site New Lambton Heights, New South Wales, Australia
  • Novartis Investigative Site Redcliffe, Queensland, Australia
View all 115 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01604278

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Malmedy/Bellevaux-Ligneuville, Belgium
  • Novartis Investigative Site Luxembourg, Belgium
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Brussels, Belgium
View all 80 locations
View Trial Details

Related conditions